AstraZeneca inks $6.9-bn breast, gastric cancer therapy deal with Daiichi

AstraZeneca said the transaction won't impact earnings this year but will make a 'significant contribution' by 2023

AstraZeneca said the transaction won't impact earnings this year but will make a 'significant contribution' by 2023 https://ift.tt/2HLWMPa March 28, 2019 at 04:50PM

Comments

Popular posts from this blog

US may impose tariffs on India, Italy for taxing internet firms like Google

No locus standi: India rejects US global religious freedom report